← Back to headlines
Silence Therapeutics Initiated at Overweight as Analyst Highlights siRNA Pipeline Potential
Silence Therapeutics plc (SLN) has been initiated at an 'Overweight' rating by an analyst who emphasizes the potential of its siRNA pipeline.
30 Jun, 13:06 — 30 Jun, 13:06
Sources
Showing 1 of 1 sources
Related Stories
Death Toll from Devastating Nepal-Tibet Floods Surpasses 470 as Rescue Operations Continue
7m ago
Deadly Floods Across Nepal and Tibet Kill Hundreds, Prompt Mass Rescue Efforts
29m ago
Nepal Flood Death Toll Rises to 469 as New Washouts Threaten Search Operations
41m ago
US, South Korea, and Japan to Conduct Trilateral Military Drills in September
46m ago